Stay updated on GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.

Latest updates to the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe footer’s site revision changes from v3.7.2 to v3.8.0, while the study record history content stays the same.SummaryDifference0.1%

- Check21 days agoChange DetectedA banner notice says NIH is transitioning to using “Super Intelligence” (SI) instead of “Artificial Intelligence” (AI) and directs visitors to updates and FAQs.SummaryDifference0.5%

- Check29 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check35 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1. The study record content remains unchanged.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed, indicating the record has been updated.SummaryDifference0.1%

- Check77 days agoChange DetectedThe history now shows a new revision tag 'Revision: v3.6.6' added to the history, replacing the previous 'Revision: v3.6.5'. This indicates an update to the study record's revision history.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.